Efficacy of Mesalamine in Irritable Bowel Syndrome

Clin Gastroenterol Hepatol. 2023 Dec;21(13):3462-3463. doi: 10.1016/j.cgh.2023.03.021. Epub 2023 Mar 29.

Authors

Cong Dai¹, Min Jiang¹, Yu-Hong Huang¹

Affiliation

¹ Department of Gastroenterology, First Affiliated Hospital, China Medical University, Shenyang City, Liaoning Province, China.

PMID: 37001712
DOI: 10.1016/j.cgh.2023.03.021

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Diarrhea / drug therapy
Humans
Irritable Bowel Syndrome* / complications
Irritable Bowel Syndrome* / drug therapy
Mesalamine* / therapeutic use

Substances

Mesalamine
Anti-Inflammatory Agents, Non-Steroidal